1 |
Mucosal immune responses to chimeric papillomavirus like particles in mice /Liu, Xiao Song. January 2001 (has links) (PDF)
Thesis (Ph.D.) - University of Queensland, 2001. / Includes bibliography.
|
2 |
The applicability of human papillomavirus immunization program for women in Hong KongTse, Cheuk-ting. January 2009 (has links)
Thesis (M.P.H.)--University of Hong Kong, 2009. / Includes bibliographical references (p. 29-34).
|
3 |
The applicability of human papillomavirus immunization program for women in Hong KongTse, Cheuk-ting., 謝綽婷. January 2009 (has links)
published_or_final_version / Community Medicine / Master / Master of Public Health
|
4 |
Systematic review of the acceptability of HPV vaccination in malesTang, Yu, 唐宇 January 2013 (has links)
Objectives To understand the acceptability of adult males, high-risk male population (MSM and bisexual men) and parents of adolescent sons and explore factors correlated with HPV vaccination acceptability
Methods A systematic searching process for literatures related to men’s HPV vaccination acceptability and published from 2000 to July, 2013 in PubMed, MEDLINE, CINAHL, Cochrane Library and Google Scholar was performed. After screening based on inclusion and exclusion criteria, qualities of all eligible studies were assessed based on the modified STROBE guideline.
Results Of 15 studies were included in this systematic review, 6 focused on adult males, 4 explored the high-risk males, five reported the parental acceptability. The HPV vaccination acceptability of adult males, high-risk male population and parents of adolescent sons was moderate or high in most reviewed studies. Knowledge about HPV and HPV vaccination, perceived susceptibility, perceived benefits and healthcare provider’s recommendation were positively correlated with HPV vaccination acceptability among adult males, high-risk males and parents of adolescent sons while high expense, side effects, safety, uncertain effectiveness and hassle of receiving a 3-shots series of HPV vaccination could diminish people’s vaccination interest.
Conclusion HPV vaccination acceptability among adult males, high-risk males and parents of adolescent sons is moderate or high. Further HPV vaccine campaign should focus on bridging the gap between the high vaccination acceptability and the low vaccination uptake among males. / published_or_final_version / Public Health / Master / Master of Public Health
|
5 |
Human papillomavirus vaccine policy in the United StatesJarrell, Jennifer C. January 2007 (has links)
Thesis (M.P.H.)--Georgia State University, 2007. / Title from file title page. Russ Toal, committee chair; Michael Eriksen, Cristen J. Suhr, committee members. Electronic text (76 p. : ill., col. map) : digital, PDF file. Description based on contents viewed Feb. 25, 2008. Includes bibliographical references (p. 66-72).
|
6 |
Human papillomavirus and cervical cancer in Western Australia /Brestovac, Brian. January 2005 (has links)
Thesis (Ph.D.)--University of Western Australia, 2005.
|
7 |
Typing of human papillomavirus in Western Cape women with cervical intraepithelial neoplasiaKay, Patti Sheryl January 2002 (has links)
Thesis (MTech (Biomedical Technology))--Cape Technikon, Cape Town, 2002 / Infection \\'ith specific high risk human papilloma"iruses (HPV) has been shown to play a causal
role in the development of ceJVical intraepithelial neoplasia (CIN) and cenical cancer in women.
The development of a prophylactic vaccine to immull.ize women against HPV infection would
play a \'ita! role in protecting women against HPV infection and ultimately ceMcal cancer.
Despite cancer of the cer\'ix being the second most common cancer in South African women, a
literature search reveals that few studies have been performed in South Africa on the types of
HPV prevalent in women with CIN or cancer ofthe ceMx.
HPVs that infect the anogenital tract have also been shown to infect the oral ca\'ity. However, the
HPV prevalence rates vary greatly between studies and the significance of the presence ofHPV
in the oral ca\'ity is still not understood.
The primary objectives of this study were to establish the HPV prevalence rate infecting women
with CIN lesions using a sensitive nested polymerase chain reaction (PCR) and to develop a
novel restriction fragment length polymorphism (RFLP) method to type the high risk mucosal
HPVs detected in these women. The secondary objective of this study was to establish the
prevalence rate and HPV types infecting the oral mucosa of women with CIN lesions and to
compare these HPV types with those detected in the ceMx.
Cemcal punch biopsies were taken from 163 women with CIN lesions and buccal cells were
collected from 33 of these participants. DNAwas extracted from the biopsies and buccal samples and PCR using CCRS primers performed to ensure sample adequacy. Nested PCR usmg
consensus degenerate primers for HPV was performed on all samples sho\\'wg sufficient
amplifiable DNA A novel restriction fragment length pol)morphism (RFLP) method was
developed to identify the 10 high risk mucosal HPVs considered human carcinogens of group 1
by the International Agency for Research on Cancer (lARC) as well as HPV 11 which is
commonly found in the oral cavity.
|
8 |
Study of the immunity of a human papillomavirus vaccine candidate /Cheung, Ying Kit. January 2003 (has links)
Thesis (M. Phil.)--Hong Kong University of Science and Technology, 2003. / Includes bibliographical references (leaves 112-129). Also available in electronic version. Access restricted to campus users.
|
9 |
Genital human papillomaviruses studies of their occurrence, type spectrum and expression /Forslund, Ola. January 1997 (has links)
Thesis (Ph. D.)--Lund University, 1997. / Added t.p. with thesis statement inserted.
|
10 |
Natural history of cervical human papillomavirus infections /Roberts, Christine C., January 2002 (has links)
Thesis (Ph. D.)--Lehigh University, 2002. / Includes vita. Includes bibliographical references (leaves 112-125).
|
Page generated in 0.1827 seconds